#philly representing with all our Fox Chase Surgical Oncology and TUHS Dept of Surgery residents and medical students #ASC2025 Assoc4AcademicSurgery Society of University Surgeons (SUS) American College of Surgeons Phil Acad of Surgery Philadelphia Eagles #FlyEaglesFly

Dr. Gail Roboz was featured in this SurvivorNet patient story to explain the common symptoms of acute myeloid #Leukemia and what patients should look for when experiencing unexplained symptoms: bit.ly/3JfkzYr

New research from a collaborative study between Dana-Farber and Broad Institute shows promise for targeted therapies for pediatric gliomas, the most common form of pediatric brain tumor. The research was published in Nature Communications. Learn more: bit.ly/45meNf6

Retired NYPD Detective Ron Licciardi spent his life in the sun with minimal sun protection. Now, after 5 battles with nonmelanoma skin cancers in 5 years, he cautions everyone about the dangers of skin cancer and the importance of early detection and sun protection.

Another week on the inpatient oncology service and this time had MULTIPLE folks come in in critical condition because they went to a quack and tried to treat their once curable cancer with supplements, tinctures, extreme diets or just ivermectin and fenbendazole. Cancer patients

This is an important drug and the class of drug is going to continue to change the paradigm and metastatic breast cancer treatment. Don’t stop -keep going.

Please join us in congratulating Alice Shaw, MD, PhD, on being named our next Chair of the Department of Medical Oncology. As Chair of the Department of Medical Oncology, Shaw will oversee more than 300 faculty and more than 80 cancer research laboratories, and will drive the

In today's #SNNewsletter: from pain to purpose — and resources to help along the way. • Dana Donofree reinvents the bra after breast cancer • Hormone therapy advice for advanced prostate cancer • How a daughter’s quick action saved her mom’s life Read more below.

Great story of love and science and pushing hard for your parents to get better care..

A subset of patients with HER2+ metastatic breast cancer are cured by current therapies. Can we increase the rate of cured patients with patient selection & sequential use of the best anti-HER2 agents currently available? High hopes in the #SAPPHO phase 2 trial to bring answers.

Will this make the #ESMO2025 presidential ? There's a lot of excitement around the KEYNOTE-905 trial and results announced by press release. I have three main concerns/questions summarised in the slide. Looking forward to seeing real data and hopefully getting answers to those

⁦Sagar Lonial MD⁩ giving a thorough and hilarious commentary on why there is still a great role for Blenrep in myeloma. ⁦MD Education⁩ #mmsm

Interesting how some of the top myeloma researcher make this argument - patients do need better options

Really happy to see this happening.⁦USAF Wounded Warrior⁩ ⁦ newsroom.woundedwarriorproject.org/2025-08-15-New…

Academic medicine is bleeding talent. The best experts are counting to retire or switch careers at an alarming rate. It’s folly to think that you can replace top talent easily — you will need 10 people to provide the level of productivity of one top talent. The effects may

Congrats Jason Westin, MD you have an amazing combination of regard for patients, clinical expertise, and you push the envelope for research.

This is probably a problem across fields, but particularly concerning for healthcare and cancer patients

Yes !

Thank you Penn Medicine - Abramson Cancer Center and Neha Vapiwala for all you do to give Megn better options when they’re facing advanced prostate cancer and it means so much to the community that you took time to help explain these options. We are grateful.